2024    2023    2022    2021    2020    2019    2018    2017    2016   

2023

Articles

21 - 

Outcome of patients with newly diagnosed AML admitted to the ICU, including preemptive admission – a multi-center study

Christophe Desprez, Achille Kouatchet, Tony Marchand, Jean Baptiste Mear, Jean Marc Tadié, Pierre Peterlin, Patrice Chevalier, Emmanuel Canet, Marie-Anne Couturier, Gaelle Guillerm et al.

Annals of Hematology, 2023, 102 (6), pp.1383-1393.

DOI : https://doi.org/10.1007/s00277-023-05205-6

 

22 - 

Roles of G4-DNA and G4-RNA in Class Switch Recombination and Additional Regulations in B-Lymphocytes

Ophelie Deze, Brice Laffleur, Michel Cogné

Molecules, 2023, 28 (3),

DOI : https://doi.org/10.3390/molecules28031159

Pubmed : 36770824

 

23 - 

Unique repetitive nucleic acid structures mirror switch regions in the human IgH locus

Ophelie Deze, Delfina Ordanoska, Delphine Rossille, Emma Miglierina, Brice Laffleur, Michel Cogné

Biochimie, 2023, 214, pp.167-175.

DOI : https://doi.org/10.1016/j.biochi.2023.08.017

Pubmed : 37678746

 

24 - 

Large granular lymphocyte leukemia: An indolent clonal proliferative disease associated with an array of various immunologic disorders

G Drillet, C Pastoret, A Moignet, T Lamy, T Marchand

La Revue de Médecine Interne, 2023, 44 (6), pp.295-306.

DOI : https://doi.org/10.1016/j.revmed.2023.03.014

Pubmed : 37087371

 

25 - 

Prolonged thrombocytopenia after CAR T-cell therapy: the role of thrombopoietin receptor agonists

Gaëlle Drillet, Faustine Lhomme, Sophie de Guibert, Guillaume Manson, Roch Houot

Blood Advances, 2023, 7 (4), pp.537-540.

DOI : https://doi.org/10.1182/bloodadvances.2022008066

Pubmed : 35930692

 

26 - 

Gilteritinib activity in refractory or relapsed FLT3-mutated acute myeloid leukemia patients previously treated by intensive chemotherapy and midostaurin: a study from the French AML Intergroup ALFA/FILO

Pierre-Yves Dumas, Emmanuel Raffoux, Emilie Bérard, Sarah Bertoli, Marie-Anne Hospital, Maël Heiblig, Yohann Desbrosses, Caroline Bonmati, Cécile Pautas, Juliette Lambert et al.

Leukemia, 2023, 37 (1), pp.91-101.

DOI : https://doi.org/10.1038/s41375-022-01742-7

Pubmed : 36376378

 

27 - 

Clinical characteristics and outcome of 318 families with familial monoclonal gammopathy: A multicenter Intergroupe Francophone du Myélome study

Charles Dumontet, Delphine Demangel, Perrine Galia, Lionel Karlin, Laurent Roche, Mathieu Fauvernier, Camille Golfier, Marie-Charlotte Laude, Xavier Leleu, Philippe Rodon et al.

American Journal of Hematology, 2023, 98 (2), pp.264-271.

DOI : https://doi.org/10.1002/ajh.26785

Pubmed : 36588407

 

28 - 

Respiratory multiplex PCR and procalcitonin to reduce antibiotic exposure in severe SARS-CoV-2 pneumonia: a multicenter randomised controlled trial

Muriel Fartoukh, Saad Nseir, Bruno Mégarbane, Yves Cohen, Antoine Lafarge, Damien Contou, Arnaud Thille, Louis-Marie Galerneau, Florian Reizine, Martin Cour et al.

Clinical Microbiology and Infection, 2023, 29 (6), pp.734-743.

DOI : https://doi.org/10.1016/j.cmi.2023.01.009

Pubmed : 36681325

 

29 - 

Phenotypic and proteomic analysis of plasma extracellular vesicles highlights them as potential biomarkers of primary Sjogren syndrome

Juliette Ferrant, Adeline Pontis, François Zimmermann, Florent Dingli, Patrick Poullet, Damarys Loew, Karin Tarte, Erwan Dumontet

Frontiers in Immunology, 2023, 14,

DOI : https://doi.org/10.3389/fimmu.2023.1207545

Pubmed : 37529039

 

30 - 

Stem cell–like reprogramming is required for leukemia-initiating activity in B-ALL Une reprogrammation de type cellule souche est nécessaire pour l’activité initiatrice de la leucémie dans B-ALL

Vincent Fregona, Manon Bayet, Mathieu Bouttier, Laetitia Largeaud, Camille Hamelle, Laura A Jamrog, Naïs Prade, Stéphanie Lagarde, Sylvie Hebrard, Isabelle Luquet et al.

Stem cell–like reprogramming is required for leukemia-initiating activity in B-ALL. Journal of Experimental Medicine, 2023, 221 (1),

DOI : https://doi.org/10.1084/jem.20230279